{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:32:18Z","timestamp":1754159538292,"version":"3.41.2"},"reference-count":29,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Urologia"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To determine the association between thyroid disorders and the Risk of developing prostate cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>\n              We conducted this review following the recommendations of the Cochrane Collaboration and the PRISMA Statement. From the moment to the present, we have conducted a search strategy using MEDLINE, WEB OF SCIENCE, and GOOGLE SCHOLAR. We included cohort and case-control studies that examined the relationship between thyroid disorders and the Risk of developing prostate cancer. We assessed the Risk of bias using the Newcastle Ottawa Quality Assessment scale. Meta-analysis was conducted in Review Manager 5.4.1 (Revman\n              <jats:sup>\u00ae<\/jats:sup>\n              ).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We included nine studies in the analysis. The studies included were classified into two groups: those that studied hypothyroidism and those that studied hyperthyroidism. The results showed no association between thyroid abnormalities and prostate cancer risk, with an HR of 1.05 (95% CI: 0.90\u20131.22). Hyperthyroidism also showed no association with an HR 1.64 (95% CI: 1.00\u20132.69), characterized by increased serum T4 and decreased TSH. There was also no significant association with hypothyroidism, with an HR of 0.85 (95% CI: 0.67\u20131.10).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Thyroid disorders were not associated with the Risk of developing prostate cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1177\/03915603251336971","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:39:19Z","timestamp":1746610759000},"page":"369-376","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between thyroid disorders and the Risk of developing prostate cancer: A systematic review and meta-analysis"],"prefix":"10.1177","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-0732","authenticated-orcid":false,"given":"Daniel Andr\u00e9s","family":"Nieva-Posso","sequence":"first","affiliation":[{"name":"UROGIV Research Group, School of Medicine, Universidad del Valle, Cali, Colombia"},{"name":"Laboratorio de Medicina Gen\u00f3mica, Department of Basic Sciences, Faculty of Health Sciences, Universidad ICESI, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1279-2015","authenticated-orcid":false,"given":"Valeria","family":"Perea Ocampo","sequence":"additional","affiliation":[{"name":"UROGIV Research Group, School of Medicine, Universidad del Valle, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5703-4546","authenticated-orcid":false,"given":"Daniel Alfonso","family":"Nieva Posso","sequence":"additional","affiliation":[{"name":"Centro de Estudios Cerebrales, School of Basic Sciences, Faculty of Health, Universidad del Valle, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-8261","authenticated-orcid":false,"given":"Herney Andr\u00e9s","family":"Garc\u00eda-Perdomo","sequence":"additional","affiliation":[{"name":"UROGIV Research Group, School of Medicine, Universidad del Valle, Cali, Colombia"},{"name":"Division of Urology\/Urooncology, Department of Surgery, School of Medicine, Universidad de Valle, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.04.021"},{"key":"e_1_3_4_3_2","unstructured":"Ferlay J Ervik M Lam F et al. Prostate. Source: Global Cancer Today. Number of New Cases in 2023. Washington DC: International Agency for Research on Cancer (IARC) https:\/\/gco.iarc.fr\/today (2023 1 March 2024)."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00243-0"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214257"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00275"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.612320"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2024.04.001"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1398272"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020156"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.937871"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33332"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0197"},{"key":"e_1_3_4_14_2","author":"Higgins JPT","year":"2011","unstructured":"Higgins JPT, Green S (eds.). Cochrane Handbook for Systematic Reviews of Interventions [Internet]. Version 5.1.0. London: The Cochrane Collaboration. https:\/\/www.cochrane-handbook.org (2011, accessed 13 December 2024).","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100"},{"key":"e_1_3_4_16_2","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919.","journal-title":"BMJ"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1123"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047730"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275568"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2104"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/01635580701307960"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0911"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215581"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14199"},{"key":"e_1_3_4_26_2","first-page":"743","article-title":"Thyroid dysfunctions and autoimmunity in breast cancer patients: a prospective case-control study","volume":"64","author":"Jha CK","year":"2021","unstructured":"Jha CK, Mishra A, Yadav SB, et al. Thyroid dysfunctions and autoimmunity in breast cancer patients: a prospective case-control study. Arch Endocrinol Metab 2021; 64: 743\u2013750.","journal-title":"Arch Endocrinol Metab"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx742"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105689"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-14-0138"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00273"}],"container-title":["Urologia Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603251336971","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03915603251336971","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603251336971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T13:35:02Z","timestamp":1753450502000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03915603251336971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1177\/03915603251336971"],"URL":"https:\/\/doi.org\/10.1177\/03915603251336971","relation":{},"ISSN":["0391-5603","1724-6075"],"issn-type":[{"type":"print","value":"0391-5603"},{"type":"electronic","value":"1724-6075"}],"subject":[],"published":{"date-parts":[[2025,5,7]]}}}